Immunocore Holdings plc
IMCR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5.8% | 4.3% | 11.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 99.5% | 98.9% | 99.1% | 99.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -6.9% | -15.2% | -3.9% | -23.1% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | $0 | -$0 | $0 | -$0 |
| Tax Expense | -$0 | $0 | $0 | -$0 |
| Net Income | $0 | -$0 | $0 | -$0 |
| % Margin | 0.8% | -10.5% | 5.4% | -28.3% |
| EPS | 0.016 | -0.21 | 0.1 | -0.47 |
| % Growth | 107.4% | -310% | 121.3% | – |
| EPS Diluted | 0.016 | -0.21 | 0.097 | -0.47 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | $0 | -$0 |
| % Margin | 4% | -6.5% | 10.6% | -18.2% |